Jason Lettmann is Chief Executive Officer of ALX ONCOLOGY HOLDINGS INC (ALXO). The company reported total compensation of $2,470,844 for fiscal year 2025.
| Salary | $724,500 |
|---|---|
| Bonus | $0 |
| Stock awards | $0 |
| Option awards | $1,447,488 |
| Non-equity incentive plan | $298,856 |
| Pension and non-qualified deferred compensation | $0 |
| All other compensation | $0 |
| Total | $2,470,844 |
A dash means the company reported no figure in that column; 0 means it reported zero. Figures are as printed, without adjustment.
Cited to the compensation disclosure ALX ONCOLOGY HOLDINGS INC filed April 20, 2026, accession 0001193125-26-163936.
| Fiscal year | Role | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension / NQDC | All other | Total |
|---|---|---|---|---|---|---|---|---|---|
| FY2025 | Chief Executive Officer | $724,500 | $0 | $0 | $1,447,488 | $298,856 | $0 | $0 | $2,470,844 |
| FY2024 | Chief Executive Officer | $700,000 | $0 | $3,168,000 | $2,480,230 | $292,600 | $0 | $0 | $6,640,830 |
Totals as disclosed in each year's own compensation disclosure for ALX ONCOLOGY HOLDINGS INC.
| Named executive officer | Role | FY2025 total |
|---|---|---|
| Jason Lettmann this page | Chief Executive Officer | $2,470,844 |
| Harish Shantharam | Chief Financial Officer | $1,700,673 |
| Jaume Pons | Former President and Chief Scientific Officer | $973,729 |
| Shelly Wong | Senior Vice President, Finance and Chief Accounting Officer | $940,405 |
The company's named executive officers for fiscal year 2025, and what it reported for each. See the full ALX ONCOLOGY HOLDINGS INC compensation brief.
Jason Lettmann's compensation sits inside ALX ONCOLOGY HOLDINGS INC's full executive and board picture — the peer group, pay against peers, incentive design and the board itself.